{
    "Trade/Device Name(s)": [
        "LDLC3 LDL-Cholesterol Gen.3",
        "LDL-Cholesterol Gen. 3"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K143691",
    "Predicate Device Reference 510(k) Number(s)": [
        "K974733",
        "K012287",
        "K060373"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBR"
    ],
    "Summary Letter Date": "December 23, 2014",
    "Summary Letter Received Date": "December 24, 2014",
    "Submission Date": "December 23, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "LDL-cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Gel Separation tube",
        "Li-heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c systems",
        "cobas c 501 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative homogeneous enzyme colorimetric assay"
    ],
    "Methodologies": [
        "Enzyme colorimetric",
        "Photometric measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for LDLC3 LDL-Cholesterol Gen. 3 assay for quantitative determination of LDL-cholesterol in human serum and plasma on Roche/Hitachi cobas c systems.",
    "Indications for Use Summary": "In vitro quantitative determination of LDL-cholesterol in human serum and plasma on Roche/Hitachi cobas c systems to aid diagnosis and treatment of lipid disorders, atherosclerosis, and various liver and renal diseases.",
    "fda_folder": "Clinical Chemistry"
}